Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?-Reference-Cited by-同舟云学术

Ought dialysis patients with atrial fibrillation be treated with oral anticoagulants?

Published:2003-02 Issue:2-3 Volume:87 Page:135-139
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Vázquez Eduardo,Sánchez-Perales Carmen,Garcı́a-Cortes Mª José,Borrego Francisco,Lozano Cristóbal,Guzmán Manuel,Gil José Manuel,Liébana Antonio,Pérez Pilar,Borrego Mª José,Pérez Vicente

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference24 articles.

1. The natural history of atrial fibrillation: incidence, risk factors and prognosis in the Manitoba follow-up study;Krahn;Am J Med,1995

2. Atrial fibrillation as an independent risk factor for stroke: the Framingham study;Wolf;Stroke,1991

3. Risk factors for stroke in type 2 diabetes mellitus. United Kingdom prospective study (UKPDS);Davis;Arch Intern Med,1999

4. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study;Petersen;Lancet,1989

5. The Stroke Prevention in Atrial Fibrillation Study Group Investigators: Final results;Circulation,1991

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter by Vázquez et al Regarding Article, “Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial”;Circulation;2023-07-25

2. The Nervous System and the Kidney;Primer on Nephrology;2022

3. ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: THE AXIS OF ROTATION BETWEEN THE POLES OF RISK;Eurasian heart journal;2018-06-30

4. Safety and Efficacy of Apixaban Versus Warfarin in Patients With Advanced Chronic Kidney Disease;Annals of Pharmacotherapy;2018-06-05

5. Incidence and characteristics of major bleeding among rivaroxaban users with renal disease and nonvalvular atrial fibrillation;Clinical and Experimental Emergency Medicine;2018-03-30